Obesity clinical trials in Alabama
38 studies for Obesity are looking for participants at sites in Alabama.
Cities in Alabama
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Pinnacle Research Group, Anniston
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lakeview Clinical Research, Guntersville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Mobile, Mobile
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Cahaba Research, Inc., Pelham
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Cullman Clinical Trials, Cullman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07845500A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Pinnacle Research Group, Anniston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843498A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Birmingham Clinical Research, Birmingham
- Cullman Clinical Trials, Cullman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Birmingham Clinical Research, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, Mobile
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Digestive Health Specialists, Dothan
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Cullman Clinical Trials, Cullman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Digestive Health Specialists, Dothan
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- Central Alabama Research, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07915609A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Dothan
- Research Site, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- University of Alabama Saint Vincent's Birmingham, Birmingham
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 29, 2026 · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fairhope
- Research Site, Huntsville
- Research Site, Mobile
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Cahaba Research - Pelham /ID# 282381, Pelham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- University of Alabama - Birmingham, Birmingham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Birmingham
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 to 45 · Women · Updated Oct 16, 2026 · NCT05124808A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
- Pinnacle Research Group, Anniston
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Oct 7, 2026 · NCT07843472Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Pinnacle Research Group LLC, Anniston
- Alliance For Multispecialty Research - Daphne, Daphne
- Alliance for Multispecialty Research Mobile, Mobile
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
- University of Alabama at Birmingham, Birmingham
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT05216042AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Pinnacle Research Group LLC, Anniston
- Univ of Alabama Birmingham, Birmingham
- Chambliss Clinical Trials LLC, Montgomery
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MFA Clinical Research, Tuscaloosa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Birmingham
- AURORA-2 Clinical Site, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Birmingham
- AURORA-1 Clinical Site, Huntsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Uni of Alabama at Birmingham, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07770841A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Advanced Cardiovascular, LLC, Alexander City
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361Time-restricted Eating for Postpartum Weight Loss
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · Women · Updated Jun 29, 2026 · NCT06491537PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT04971720Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 to 65 · All sexes · Updated Apr 7, 2026 · NCT06736028CARBON: UAB Cardiovascular Research Biobank
- University of Alabama at Birmingham, Birmingham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05067231FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
Recruiting
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT07220213Inspire HER: Inspiring the Heart and Emotions for Radical Health
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 30 to 79 · Women · Updated Dec 29, 2025 · NCT06966258From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.